Making waves in cancer diagnostics
About Us
Our Story
Celer Diagnostics is the culmination of the research performed by Dr. Faezah Shekari and her team.
The team created the company Firoozeh Diagnosis Technology (FDT), which is focused on the diagnosis and prognosis of cancer progression based on liquid biopsy.
Liquid Biopsy
Liquid biopsy is an advanced cancer diagnostic test carried out using biofluids such as blood, CSF (Cerebrospinal Fluid), plasma and urine for cancer detection.
Liquid biopsy test can be used to detect cancer in early stages. Liquid biopsy is a non-invasive diagnostic test which uses circulating nucleic acids, circulating tumor cells (CTC) and exosomes as a biomarker for diagnosis of cancer.
Exosome-Based Diagnosis
Exosomes are a type of extracellular vesicle that contain constituents (protein, DNA, and RNA) of the cells that secrete them.
EV (exosome)-based diagnosis (EBD) is a type of liquid biopsy. EBD is a revolutionary, minimally invasive technique that has opened previously unexpected perspectives in the field of medicine with many ongoing clinical trials and FDA approved products.
Celer Diagnostic Kits
Celer Kits are EV-based diagnostics kits designed to detect, and even in some cases predict breast cancer.
Celer Kits are fast, cost effective and are minimally invasive. All needed is 5 cc blood of the patient and the results can be obtained in less than 2 hours.
Celer Kits observe 7 biometrics, five of which are also observed in physical biopsy and two additional biomarkers that increase the accuracy of the test significantly.
Our Team
We Are redefining cancer diagnostics
CEO - Product
Faezeh Shekari
- Has a Ph.D. in Developmental Biology, now is an associate professor.
- Chair of ISEV Rigor and Standardization task force (International Society of Extracellular Vesicles).
R&D Lead
Maryam Bagherian
- Adult Hematologist & Medical Oncologist.
- Responsible for designing Clinical/Human Trials and analyzing epidemiologic data.
Commercialization & Marketing Lead
Eideh Tabassi
- Masters in business administration.
- Extensive experience in marketing and growth strategies development, campaigning and business design.
Pharmaceutical Regulatory Affairs Manager
Ali Najafi Hajialvani
- Bachelor’s degree in Engineering and currently enrolled in MBA program specifically focused on Pharma Marketing.
- Ali involved in many start-ups in life science and tech.
Technical Assitant
Maryam Ferdousi
- Ph.D. degree in Molecular and Cellular biology.
- Responsible for leading the development of our new diagnostic kit for colon cancer.
Celer Kit Benefits
Our offered advantages
Non-Invasive Procedure
Celer Kits are based on a type of liquid biopsy that uses biofluids such as blood, CSF (Cerebrospinal Fluid), plasma and urine for cancer detection, and thus very safe to undertake.
Fast & Cost-Effective
Due to simple sampling and procedures, the tests are very cost-effective. In addition, results can be extracted in short time compared to regular biopsy.
Accurate Results
Celer Kits check for 7 biometrics, including ASPH protein, in blood samples, whereas 5 biometrics are observed in physical biopsy.
No Human Error
Despite the prone-to-human-error results in regular biopsy, Celer Kits obtain reliable results with no operation errors
Stay Healthy
with Regular Checkups
Strong evidence shows early diagnosis of cancer can improve the survival rate significantly. So take a proactive approach for your health and do necessary checkups regularly.
Contact us
for more details
- Phone: +1-647-957-9590
- Email: Info@celerdiagnostics.com
- Address: 1st Canadian Place, 100 King St. West. Suite #56120, Toronto
